|
German Federal Joint Committee (G-BA) Issues Final Assessment Report For …
Daily Markets (press release) The European Medicines Agency’s (the “EMA”) Committee for Medicinal Products for Human Use has accepted PIX306, CTI’s ongoing randomized controlled Phase 3 clinical trial, which compares PIXUVRI-rituximab to gemcitabine-rituximab in patients who … |
New textile able to absorb more influenza antibodies – The Japan TimesThe Japan TimesResearchers have come up with new technology that lets textiles absorb more flu antibodies, a development likely to make face masks more effective in warding off the f…
 6abc.com |
SIMPONI (GOLIMUMAB) Receives FDA Approval For Ulcerative Colitis
PipelineReview.com (press release) HORSHAM, PA, USA I May 15, 2013 I Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SIMPONI® (golimumab) for the treatment of moderately to severely active ulcerative colitis (UC) in adult patients … FDA: Arthritis drug OKed to treat bowel diseaseThe Star-Ledger – NJ.com |
All about feedUsing egg yolk antibodies to cut poultry nitrogen emissionsAll about feedEgg yolk antibodies are economic alternatives for administering in feed to poultry. Supplementation of feed grade antibodies into poultry diets can be a potential ap…
Klinisch belangrijk effect van daclizumab bij MSCare 4 Cure (abonnement)Het gehumaniseerde monoklonale antilichaam daclizumab high-yield process (HYP) zou een additionele optie kunnen worden bij de behandeling van relapsing-remitting MS (RRMS). SC-dacl…
Making Good Results Even Better: The Evolving Role of Radiotherapy in …Cancer NetworkTwo phase III studies addressed the role of RT in the management of stage I and II DLBCL in the pre-rituximab (Rituxan) era. The SWOG study[1] compared 3 cycles of C…
Alethia Biotherapeutics Announces the Issuance of a United States Patent for …Marketwire (press release)MONTREAL, QUEBEC–(Marketwired – May 16, 2013) – Alethia Biotherapeutics Inc., a privately held biotechnology company focusing on the development …
AnaptysBio Awarded US Government Contract To Develop Anti-Ricin AntibodiesWall Street Journal (press release)SAN DIEGO, May 16, 2013 /PRNewswire/ — AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the receipt of a contr…
AnaptysBio Awarded U.S. Government Contract To Develop Anti-Ricin AntibodiesPR Newswire (press release)SAN DIEGO, May 16, 2013 /PRNewswire/ — AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the receipt of a contract aw…
|
Computers to extract huge amounts of relevant data
The Upcoming “We want to continue to grow internationally,” says Dr Tim Hiddemann, co-founder and CEO of antibodies-online GmbH in Aachen, Germany. Together with Dr Andreas Kessel, he started the company as a spin-off of the RWTH Aachen in 2006. By now, they … |